Tetrac-decorated chitosan-coated PLGA nanoparticles as a new platform for targeted delivery of SN38

References

• Alibolandi M, Rezvani R, Farzad SA, et al. Tetrac-conjugated polymersomes for integrin-targeted delivery of camptothecin to colon adenocarcinoma in vitro and in vivo. Int J Pharm. 2017;532:581–594.
   PubMed Web of Science ®Google Scholar
• Li Y, Song L, Lin J, et al. Programmed nanococktail based on pH-responsive function switch for self-synergistic tumor-targeting therapy. ACS Appl Mater Interfaces. 2017;9:39127–39142.
   PubMed Web of Science ®Google Scholar
• Li Y, Wu H, Yang X, et al. Mitomycin C-soybean phosphatidylcholine complex-loaded self-assembled PEG-lipid-PLA hybrid nanoparticles for targeted drug delivery and dual-controlled drug release. Mol Pharm. 2014;11:2915–2927.
   PubMed Web of Science ®Google Scholar
• Davis FB, Mousa SA, O’Connor L, et al. Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. Circulat Res. 2004;94:1500–1506.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Abnous K, Mohammadi M, et al. Extensive preclinical investigation of polymersomal formulation of doxorubicin versus Doxil-mimic formulation. J Control Release. 2017;264:228–236.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Taghdisi SM, Ramezani P, et al. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo. Int J Pharm. 2017;19:352–364.
   Web of Science ®Google Scholar
• Brandhonneur N, Hatahet T, Amela-Cortes M, et al. Molybdenum cluster loaded PLGA nanoparticles: an innovative theranostic approach for the treatment of ovarian cancer. Eur J Pharm Biopharm. 2018;125:95–105.
   PubMed Web of Science ®Google Scholar
• Li X, Jiang X. Microfluidics for producing poly (lactic-co-glycolic acid)-based pharmaceutical nanoparticles. Adv Drug Deliv Rev. 2017;pii:S0169-409X(17)30318-6.
   Web of Science ®Google Scholar
• Taghavi S, Ramezani M, Alibolandi M, et al. Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery. Cancer Lett. 2017;400:1–8.
   PubMed Web of Science ®Google Scholar
• Babu A, Amreddy N, Muralidharan R, et al. Chemodrug delivery using integrin-targeted PLGA-chitosan nanoparticle for lung cancer therapy. Sci Rep. 2017;7:14674.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Abnous K, Hadizadeh F, et al. Dextran-poly lactide-co-glycolide polymersomes decorated with folate-antennae for targeted delivery of docetaxel to breast adenocarcinima in vitro and in vivo. J Control Release. 2016;241:45–56.
   PubMed Web of Science ®Google Scholar
• Park J, Pei Y, Hyun H, et al. Small molecule delivery to solid tumors with chitosan-coated PLGA particles: a lesson learned from comparative imaging. J Control Release. 2017;268:407–415.
   PubMed Web of Science ®Google Scholar
• Kang BS, Choi JS, Lee SE, et al. Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated PLGA nanoparticles. Carbohydr Polym. 2017;159:39–47.
   PubMed Web of Science ®Google Scholar
• Li Y, Lin J, Ma J, et al. Methotrexate–camptothecin prodrug nanoassemblies as a versatile nanoplatform for biomodal imaging-guided self-active targeted and synergistic chemotherapy. ACS Appl Mater Interfaces. 2017;9:34650–34665.
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Labhasetwar V. Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol Pharm. 2005;2:373–383.
   PubMed Web of Science ®Google Scholar
• Liang XJ, Chen C, Zhao Y, et al. Circumventing tumor resistance to chemotherapy by nanotechnology. Methods Mol Biol. 2010;596:467–488.
   PubMedGoogle Scholar
• Alibolandi M, Abnous K, Anvari S, et al. CD133-targeted delivery of self-assembled PEGylated carboxymethylcellulose-SN38 nanoparticles to colorectal cancer. Artif Cells Nanomed Biotechnol. 2018[Mar 8]; [1–11]. DOI:10.1080/21691401.2018.1446969
   PubMed Web of Science ®Google Scholar
• Prasad S, Dangi JS. Development and characterization of pH responsive polymeric nanoparticles of SN-38 for colon cancer. Artif Cells Nanomed Biotechnol. 2016;44:1824–1834.
   PubMed Web of Science ®Google Scholar
• Einafshar E, Asl AH, Nia AH, et al. New cyclodextrin-based nanocarriers for drug delivery and phototherapy using an irinotecan metabolite. Carbohydr Polym. 2018;194:103–110.
   PubMed Web of Science ®Google Scholar
• Kibria G, Hatakeyama H, Harashima H. Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system. Arch Pharm Res. 2014;37:4–15.
   PubMed Web of Science ®Google Scholar
• Bharali DJ, Yalcin M, Davis PJ, et al. Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer. Nanomedicine. 2013;8:1943–1954.
   PubMed Web of Science ®Google Scholar
• Davis PJ, Glinsky GV, Lin HY, et al. Cancer cell gene expression modulated from plasma membrane integrin alphavbeta3 by thyroid hormone and nanoparticulate tetrac. Front Endocrinol. 2014;5:240.
   PubMed Web of Science ®Google Scholar
• Sudha T, Bharali DJ, Sell S, et al. Nanoparticulate tetrac inhibits growth and vascularity of glioblastoma xenografts. Horm Canc. 2017;8:157–165.
   PubMed Web of Science ®Google Scholar
• Davis PJ, Hercbergs A, Luidens MK, et al. Recurrence of differentiated thyroid carcinoma during full TSH suppression: is the tumor now thyroid hormone dependent? Horm Canc. 2015;6:7–12.
   PubMed Web of Science ®Google Scholar
• Yoshida T, Gong J, Xu Z, et al. Inhibition of pathological retinal angiogenesis by the integrin alphavbeta3 antagonist tetraiodothyroacetic acid (tetrac). Exp Eye Res. 2012;94:41–48.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Ramezani M, Abnous K, et al. In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer. J Control Release. 2015;209:88–100.
   PubMed Web of Science ®Google Scholar
• Sudha T, Bharali DJ, Yalcin M, et al. Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac. Int J Nanomed. 2017;12:1305–1315.
   PubMed Web of Science ®Google Scholar
• Mehdizadeh M, Rouhani H, Sepehri N, et al. Biotin decorated PLGA nanoparticles containing SN-38 designed for cancer therapy. Artif Cells Nanomed Biotechnol. 2017;45:495–504.
   PubMed Web of Science ®Google Scholar
• Li F, Jiang T, Li Q, et al. Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer? Am J Cancer Res 2017;7:2350–2394.
   PubMed Web of Science ®Google Scholar
• Dhanapal J, Balaraman Ravindrran M. Chitosan/poly (lactic acid)-coated piceatannol nanoparticles exert an in vitro apoptosis activity on liver, lung and breast cancer cell lines. Artif Cells Nanomed Biotechnol. 2018;3:1–9.
   Web of Science ®Google Scholar
• Davis PJ, Incerpi S, Lin H-Y, et al. Thyroid hormone and P-glycoprotein in tumor cells. BioMed Res Int. 2015;2015:168427.
   PubMed Web of Science ®Google Scholar